Chief Executive Officer
Current➢ Support operations and strategic planning around market access, clinical trials, intellectual property development, commercial scaling, and federal reporting obligations➢ Lead clinical and regulatory operations including eCTD technical writing of commercial IND package that resulted in FDA clearance and IRB approved Phase II clinical study for subcutaneous biologic➢ Support various research projects including patent-pending potency assay program, downstream bioprocessing, and grant collaboration projects➢ Manage financial budgets, investor relations, and support manufacturing cost accounting within Enterprise Resource Planning software